Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > Lobe is another mmed

<< Previous

Bullboard Posts

Next >>

Comment by Ryjo1980on Dec 12, 2020 2:16pm

235 Views

Post# 32093720

RE:Lobe is another mmed

What's the deal with all the adds and bullshit here?? And I appreciate the clarity and message of your post.

Joey2834 wrote: Buddy relax he's not pumping. I'm invested in both its psychedelic company like the one your invested in just newer and alll these stocks are hot right now. I'm waiting on the nasal spray. Talk nice next time and be happier. Like I will be tomorrow up another 30%

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing